What are the guideline-recommended antihypertensive medication choices and practical dosing strategies for different clinical scenarios in the hospital ward?

Management of Hypertension: Medication Selection by Clinical Scenario

General Principles for Ward Management

Start with ACE inhibitors/ARBs or calcium channel blockers (CCBs) for non-Black patients, and CCBs or thiazide diuretics for Black patients, using combination therapy when BP is ≥20/10 mmHg above target. 1

---

Initial Drug Selection by Patient Population

Non-Black Patients

• First-line monotherapy: ACE inhibitor or ARB (Grade B) 2
• Alternative first-line: Long-acting CCB, thiazide/thiazide-like diuretic 2, 1
• β-blockers: Only if age <60 years (Grade B); NOT recommended as first-line if ≥60 years (Grade A) 3, 2

Black Patients

• First-line: ARB + CCB combination OR CCB + thiazide diuretic 1
• Avoid: ACE inhibitors as monotherapy (Grade A) 2
• Rationale: ACE inhibitors show reduced efficacy in Black patients without concurrent diuretic or CCB

---

Stepwise Treatment Algorithm

Step 1: Monotherapy vs. Combination

• Monotherapy appropriate for:

  • Grade 1 hypertension (140-159/90-99 mmHg) in low-risk patients 1
  • Patients >80 years or frail 1

• Start combination therapy if:

  • SBP ≥20 mmHg above target OR DBP ≥10 mmHg above target 3, 2
  • Grade 2 hypertension (≥160/100 mmHg) 1
  • High-risk patients (CVD, CKD, diabetes, organ damage) 1

Step 2: Dual Therapy

Preferred combinations (Grade A-B):

• ACE inhibitor/ARB + CCB (Grade A) 2
• ACE inhibitor/ARB + thiazide diuretic (Grade B) 2
• CCB + thiazide diuretic (Grade B) 2

AVOID: ACE inhibitor + ARB combination (Grade A) 3, 2

CAUTION: Non-dihydropyridine CCB + β-blocker (risk of bradycardia/heart block) 3, 2

Step 3: Triple Therapy

• Standard regimen: ACE inhibitor/ARB + CCB + thiazide diuretic 1
• Use longer-acting thiazide-like diuretics (chlorthalidone, indapamide) over hydrochlorothiazide (Grade B) 2
• Monitor potassium to avoid hypokalemia (Grade C) 3, 2

Step 4: Resistant Hypertension

Definition: BP >140/90 mmHg on 3 drugs including a diuretic at optimal doses 1

Before adding 4th agent, exclude:

• Poor BP measurement technique
• White coat effect
• Non-adherence
• Suboptimal drug choices/doses
• Secondary causes 1

Fourth-line agent:

• Spironolactone (preferred if K+ <4.5 mmol/L and eGFR >45 mL/min/1.73m²) 1
• Alternatives if spironolactone contraindicated: Amiloride, doxazosin, eplerenone, clonidine, or β-blocker 1

---

Practical Ward Dosing Strategies

Target Blood Pressure

• General target: <140/90 mmHg (Grade C for SBP, Grade A for DBP) 2
• ACC/AHA target: <130/80 mmHg 4, 5
• Achieve control within 3 months 1
• Individualize for elderly/frail patients 1

Common Pitfall: Asymptomatic Inpatient Hypertension

Critical ward management principle: Avoid PRN IV antihypertensives for asymptomatic BP elevation 6, 7, 8, 9

• No guidelines exist for managing asymptomatic elevated BP in hospital 6
• IV hydralazine/labetalol/enalaprilat are frequently misused for SBP <180 mmHg without symptoms 7, 8, 9
• Associated harms: Excessive BP drops (>25% reduction in 6 hours in 32.6% of cases), increased adverse events, longer hospital stays 7, 9

Correct approach:

• Continue or optimize oral home antihypertensive regimen 8, 9
• Intensify oral regimen if needed rather than using PRN IV agents 8, 9
• Reserve IV antihypertensives for hypertensive emergencies only (see below)

---

Hypertensive Emergencies (Ward Recognition & Transfer)

Definition

• BP >180/120 mmHg PLUS acute target organ damage 5, 6
• Examples: acute MI, acute pulmonary edema, acute stroke, aortic dissection, eclampsia

Management

• Transfer to ICU immediately 5
• Use continuous IV infusions (not boluses) 5

Drug selection by scenario:

Clinical Scenario	Preferred IV Agent	Key Considerations
Acute aortic dissection	Esmolol or labetalol	Target SBP ≤120 mmHg within 20 min; β-blockade first [5]
Acute pulmonary edema	Nitroglycerin, clevidipine, nitroprusside	Avoid β-blockers [5]
Acute coronary syndrome	Nitroglycerin, esmolol, labetalol	Check for PDE-5 inhibitor use before nitrates [5]
Eclampsia/preeclampsia	Hydralazine, labetalol, nicardipine	Avoid ACE-I/ARB/nitroprusside [5]
Acute stroke	Nicardipine, clevidipine	Follow stroke-specific protocols [5]

---

Special Populations

Elderly (≥65 years)

• Avoid β-blockers as first-line (Grade A) 2
• Consider monotherapy initially if frail 1
• Target BP: Individualize based on frailty; may accept <140/90 mmHg rather than <130/80 mmHg 1

Diabetes/CKD/CVD

• Start treatment immediately even with Grade 1 hypertension 1
• Preferred agents: ACE inhibitor or ARB for renoprotection
• Target: <130/80 mmHg 1

Isolated Systolic Hypertension

• First-line: Thiazide diuretic (Grade A), long-acting dihydropyridine CCB (Grade A), or ARB (Grade B) 3

---

Key Medication Considerations

Single-Pill Combinations

• Improve adherence 2, 4
• Recommended combinations: ACE-I/ARB + CCB, ACE-I/ARB + diuretic 2
• Once-daily dosing preferred 1

Avoid Hypokalemia

• Monitor potassium with thiazide monotherapy (Grade C) 3, 2
• Consider potassium-sparing diuretic if K+ drops

Drug Interactions

• Never combine ACE inhibitor + ARB (Grade A) 3, 2
• Caution with non-dihydropyridine CCB + β-blocker (bradycardia risk) 3, 2

---

Common Ward Errors to Avoid

1. Using PRN IV antihypertensives for asymptomatic BP <180/120 mmHg 7, 8, 9
2. Holding home antihypertensives during hospitalization (40.8% of patients in one study) 8
3. Failing to intensify regimen at discharge (62.4% missed opportunity) 8
4. Using β-blockers as first-line in patients ≥60 years 3, 2
5. Starting ACE inhibitor monotherapy in Black patients 2
6. Combining ACE inhibitor + ARB 3, 2